Pharmacological Zn supplementation increased IL-1RA:IL-1 ratio, suggesting an ability of Zn to alleviate pro-inflammatory responses because of a negative correlation between IL-1RA:IL-1 ratio and inflammatory bowel disease [37,38]. The gene discussed is IL1B; the disease is inflammatory bowel disease.